In order to do so, we generated cell lines with a doxycycline-inducible RFP plus shRNA targeting CTCF. Given the suppression of CTCF following TGFβ treatment and in mesenchymal breast cancer cell lines, we expected the knockdown to induce mesenchymal traits. This evidence concerns the gene CTCF and breast carcinoma.